Feasibility and safety of nintedanib in combination with nivolumab in pretreated patients with advanced or metastatic adenocarcinoma of the lung – An AIO phase Ib/II trial (2026) Reck M, Waller C, Sadjadian P, Kambartel K, Grohé C, Sendler A, Reinmuth N, et al. Journal article Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition (2024) Saal J, Bald T, Eckstein M, Ralser DJ, Brossart P, Ellinger J, Hölzel M, Klümper N Journal article EpCAM-positive disseminated cancer cells in bone marrow impact on survival of early-stage NSCLC patients (2022) Mederer T, Elsner F, Robold T, Großer C, Neu R, Ried M, Bleicher S, et al. Journal article Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT) (2021) Tufman A, Neumann J, Manapov F, Sellmer L, Jung A, Kauffmann-Guerrero D, Kahnert K, et al. Journal article Primary lung carcinoma in children and adolescents – Clinical characteristics and outcome of 12 cases from the German registry for rare paediatric tumours (STEP) (2021) Voggel S, Abele M, Seitz C, Agaimy A, Vokuhl C, Dirksen U, Bier A, et al. Journal article Sensitive and specific detection of EML4-ALK rearrangements in non-small cell lung cancer (NSCLC) specimens by multiplex amplicon RNA massive parallel sequencing (2014) Moskalev E, Frohnauer J, Merkelbach-Bruse S, Schildhaus HU, Dimmler A, Schubert T, Boltze C, et al. Journal article